What is the recommended dose of cefdinir (Omnicef) for treating sinusitis in adults with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosage for Sinusitis in Adults with Normal Renal Function

For adults with normal renal function, the recommended dose of cefdinir (Omnicef) for treating acute bacterial sinusitis is 300 mg twice daily for 10 days or 600 mg once daily for 10 days. 1, 2

Dosing Recommendations

The FDA-approved dosage for cefdinir in adults with acute maxillary sinusitis is:

  • 300 mg twice daily for 10 days, OR
  • 600 mg once daily for 10 days 2

This dosing regimen is supported by clinical guidelines from the American Academy of Otolaryngology-Head and Neck Surgery, which includes cefdinir as an appropriate alternative treatment option for patients with penicillin allergies 1.

Dosage Adjustments

For patients with renal impairment, dosage adjustment is required:

  • For adults with creatinine clearance <30 mL/min: 300 mg once daily 2
  • For patients on hemodialysis: 300 mg every other day, with an additional 300 mg dose after each hemodialysis session 2

Clinical Efficacy

Cefdinir has demonstrated good clinical efficacy in the treatment of acute bacterial rhinosinusitis:

  • Clinical cure rates of approximately 90% in randomized controlled trials 3
  • Similar efficacy to amoxicillin-clavulanate, which is considered a first-line treatment 3, 4
  • Effective against common sinusitis pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 5, 6

Administration Considerations

  • Cefdinir can be administered without regard to meals 2
  • Once-daily dosing (600 mg) provides similar efficacy to twice-daily dosing (300 mg) 3, 6
  • The convenient once-daily dosing option may improve patient adherence 4

Treatment Duration

The recommended duration of treatment for acute bacterial sinusitis is 10 days 1, 2. Treatment response should be reassessed after 72 hours of therapy to determine if the current regimen is effective or if alternative treatment should be considered 1.

Common Side Effects

The most common adverse effect associated with cefdinir is mild diarrhea, occurring in approximately 20% of patients 3. Other potential side effects include:

  • Nausea
  • Headache
  • Abdominal pain
  • Vaginal candidiasis

Important Considerations

  1. Patient Selection: Cefdinir is particularly useful in areas with high rates of beta-lactamase production in H. influenzae and M. catarrhalis 6.

  2. Alternative to Amoxicillin: Cefdinir is an appropriate alternative for patients with non-type I penicillin allergies 7, 1.

  3. Monitoring: Assess treatment response after 72 hours; if no improvement is observed, reevaluate the diagnosis or consider alternative antibiotics 1.

  4. Resistance Concerns: In areas with high prevalence of penicillin-resistant S. pneumoniae, cefdinir may be a valuable option, though high-dose amoxicillin-clavulanate remains the preferred first-line therapy 7, 1.

Cefdinir represents an effective treatment option for acute bacterial sinusitis in adults with normal renal function, with the convenience of once-daily or twice-daily dosing and a favorable side effect profile compared to some alternative antibiotics.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.